blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4404923

EP4404923 - COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  27.06.2024
Database last updated on 16.11.2024
FormerThe international publication has been made
Status updated on  01.04.2023
Most recent event   Tooltip06.11.2024New entry: Additional fee for renewal fee: despatch of communication + time limit 
Applicant(s)For all designated states
Alkalay, Rachel
Museum Tower, 6-7th Fl.
4 Berkovitz Street
P.O. Box 31
6423806 Tel Aviv / IL
[2024/31]
Inventor(s)01 / see applicant
...
 [2024/31]
Representative(s)Berggren Oy
P.O. Box 16
Eteläinen Rautatiekatu 10A
00101 Helsinki / FI
[2024/31]
Application number, filing date22872323.522.09.2022
[2024/31]
WO2022IB58945
Priority number, dateUS202163247328P23.09.2021         Original published format: US 202163247328 P
[2024/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2023047317
Date:30.03.2023
Language:EN
[2023/13]
Type: A1 Application with search report 
No.:EP4404923
Date:31.07.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 30.03.2023 takes the place of the publication of the European patent application.
[2024/31]
Search report(s)International search report - published on:US30.03.2023
ClassificationIPC:A61K31/05, A61K36/25, A61K36/258, A61K36/324, A61K36/424, A61K36/53, A61K36/537, A61P29/00, A61K36/534, A61K36/738, A61P1/00, A61P3/00, A61P5/00, A61P7/00, A61P31/00
[2024/31]
CPC:
A61P1/00 (EP,IL); A61K36/185 (EP,IL); A61K36/22 (EP,IL);
A61K36/258 (EP,IL); A61K36/324 (EP,IL); A61K36/424 (EP,IL);
A61K36/53 (EP,IL); A61K36/71 (EP,IL); A61P25/28 (EP,IL);
A61P29/00 (EP,IL); A61P3/04 (EP,IL); A61P3/10 (EP,IL);
A61P31/14 (EP,IL); A61P5/00 (EP,IL) (-)
C-Set:
A61K36/185, A61K2300/00 (EP);
A61K36/22, A61K2300/00 (EP);
A61K36/258, A61K2300/00 (EP);
A61K36/324, A61K2300/00 (EP);
A61K36/424, A61K2300/00 (EP);
A61K36/53, A61K2300/00 (EP);
A61K36/71, A61K2300/00 (EP)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/31]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG ODER PRÄVENTION VON ENTZÜNDLICHEN ERKRANKUNGEN EINSCHLIESSLICH DIABETES UND SCHILDDRÜSENERKRANKUNGEN[2024/31]
English:COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES[2024/31]
French:COMPOSITIONS ET MÉTHODES POUR TRAITER OU PRÉVENIR DES MALADIES INFLAMMATOIRES, Y COMPRIS LE DIABÈTE ET LES MALADIES THYROÏDIENNES[2024/31]
Entry into regional phase26.03.2024National basic fee paid 
26.03.2024Search fee paid 
26.03.2024Designation fee(s) paid 
26.03.2024Examination fee paid 
Examination procedure24.03.2024Observations by third parties
26.03.2024Examination requested  [2024/31]
30.10.2024Amendment by applicant (claims and/or description)
Fees paidPenalty fee
Additional fee for renewal fee
30.09.202403   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2009146102  (UNIV BRANDEIS [US], et al);
 [A]WO2012094636  (ELCELYX THERAPEUTICS INC [US], et al);
 [XYA]US2015004266  (BABISH JOHN GEORGE [US], et al);
 [Y]KR20200084215  (DONG-EUI UNIV INDUSTRY-ACADEMIC COOPERATION FOUNDATION [KR]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.